Astrazeneca, China university in research deal

Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic instit...

December 19, 2012 | Wednesday | News
Phylogica extends collaboration with Janssen Biotech

Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...

January 31, 2013 | Thursday | News
AstraZeneca, BMS gets positive regulatory feedback on Type 2 diabetes drug

Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided Ast...

November 29, 2013 | Friday | Regulatory
Regeneron acquires Sanofi eye care antibodies

Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from San...

May 6, 2013 | Monday | News
Teva, Xenon enter $335 mn deal for pain drug

Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative dev...

December 12, 2012 | Wednesday | News
Linaclotide phase III trial initiated in China

Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...

September 11, 2013 | Wednesday | News
Singapore firm, Stehlin Foundation collaborate on anti-cancer drug

Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement ...

October 15, 2013 | Tuesday | News
AseaCyte gets BioSpectrum award for drug discovery efforts

A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...

March 15, 2013 | Friday | Influencers
Abraxane cancer trial shows positive results in Australia

Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic me...

October 29, 2012 | Monday | News
Astellas, Ambit terminate cancer drug deal

Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...

March 12, 2013 | Tuesday | News
Roche launches FLOW system

Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...

December 18, 2013 | Wednesday | News
TB prevention faces gap of $1.6bn: WHO estimates

Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...

April 24, 2013 | Wednesday | News
Edison Pharma, DSP enter $4 bn metablosim drug deal

Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...

February 4, 2014 | Tuesday | News
Gilead files NDA for Hep C drug in Japan

Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...

June 30, 2014 | Monday | News
GSK gets EU nod for metastatic melanoma inhibitor

Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a ...

April 24, 2013 | Wednesday | Regulatory
Alchemia gets new CEO

Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appoint...

April 24, 2013 | Wednesday | News
Merck Millipore enhances bioavailability portfolio

Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosag...

October 10, 2012 | Wednesday | News
Singapore scientists, clinicians collaborate on 8 projects

Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of d...

April 24, 2012 | Tuesday | News
Boehringer Ingelheim enriches drug pipeline

Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...

July 24, 2012 | Tuesday | News
China will overtake Japan in R&D spending: Report

Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...

August 8, 2013 | Thursday | News
Astellas gets FDA nod for kidney transplant drug

Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...

July 22, 2013 | Monday | News
Global collaborations is the way forward for drug discovery

Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...

December 19, 2012 | Wednesday | Analysis
NIH gives $2.2 mn to VaxInnate for dengue vaccine

Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provi...

April 5, 2013 | Friday | News
Janssen to develop therapy for immunological diseases

Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and c...

April 24, 2012 | Tuesday | News
European Commission nod for Novartis' Exjade

Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring ch...

December 26, 2012 | Wednesday | Regulatory